Bain Capital Private Equity’s acquisition of DSM Sinochem Pharmaceuticals

Clifford Chance has advised Royal DSM (“DSM”) and Sinochem Group on the disposal of their 50/50 joint venture DSM Sinochem Pharmaceuticals (“DSP”), the global leader in…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Michael Patrini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here